| CAS No.: | 40077-57-4 |
|---|---|
| Formula: | C147h238n44o42s |
| EINECS: | 40077-57-4 |
| Type: | Pharmaceutical Intermediates |
| Appearance: | Powder |
| Quality: | Technical |
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier Matrixyl 3000 is a trademarked peptide composition developed by Sederma Inc. in France. It is the first anti-aging ingredient based on the matrikine peptide technology. Matrixyl 3000 is composed of the matrikines palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7. These two peptides work synergistically to restore and maintain the skin's youthful appearance by signaling to cells to produce more collagen. Numerous studies have proven the anti-aging and anti-wrinkle efficacy of Matrixyl 3000.
For example, a clinical study involving female participants demonstrated that after just 2 months of treatment with Matrixyl 3000, the area occupied by deep wrinkles was reduced by 45%, and the skin's tonicity increased by nearly 20%. In a separate 2 month clinical study conducted on a panel of men, the anti-wrinkle efficacy of Matrixyl 3000 was confirmed. As the wrinkle volume decreases (-17.1%), the spread angle increases (+5.4%), which leads to a reduction of the surface occupied by deep wrinkles of nearly 30%.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}